2016 Physician Quality Reporting System Data Collection Form: Hepatitis C (for patients aged 18 and over)

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "2016 Physician Quality Reporting System Data Collection Form: Hepatitis C (for patients aged 18 and over)"

Transcription

1 2016 Physician Quality Reporting System Data Collection Form: Hepatitis C (for patients aged 18 and over) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory reporting. Review your PQRS Submission Summary report, available after entering your data, to ensure this is not an issue. Each measure answer is identified as Performance Met (PM), Performance Not Met (PNM) or Performance Exclusion (PE). More information on this rule is available within the Covisint PQRS Web Application. Patient sample criteria for the Hepatitis C Measures Group are: patients aged 18 years and older, with a specific diagnosis of chronic Hepatitis C accompanied by a specific patient encounter: One of the following diagnosis codes indicating chronic hepatitis C: ICD-10-CM: B18.2 one of the following patient encounter codes: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99406, Measure #87 only needs to be reported if initiation of antiviral treatment took place before October of the measurement year (12 weeks before the end of the measurement period) Measure #401 only needs to be reported when the patient also has the following diagnosis code indicating cirrhosis: ICD-10-CM: K70.30, K70.31, K74.60, K74.69 Note: Refer to the Covisint PQRS2016 Applicable Measure Group Codes document which contains a list of diagnosis, encounter, and procedure codes for each measures group. Not all measures groups require all 3 code types. REFER TO THE HEPATITIS C MEASURES GROUP IN THE CMS 2016 PQRS MEASURES GROUPS SPECIFICATIONS MANUAL FOR CLINICAL RECOMMENDATIONS FURTHER INFORMATION

2 Page 2 of 9 Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Medical Record Number: Patient Insured - Traditional Medicare*: Medicare Advantage: Other: *Note: A minimum of 11 patients must be Traditional Medicare Part B Appointment Date: / / (1/1/16 12/31/16) mm dd yyyy ICD-10 Diagnosis Code: CPT Encounter (visit) Code: CPT Procedure Code: N/A

3 Page 3 of 9 Physician Quality Reporting Measure # 84 : Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment Percentage of patients aged 18 years and older with a diagnosis of chronic Hepatitis C who started antiviral treatment within the 12-month reporting period for whom quantitative Hepatitis C virus (HCV) ribonucleic acid (RNA) testing was performed within 12 months prior to initiation of antiviral treatment RNA testing for Hepatitis C documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis C Patient starting antiviral treatment for Hepatitis C during the measurement period PM RNA testing for Hepatitis C was not documented as performed within 12 months prior to initiation of antiviral treatment for Hepatitis C, reason not given Patient starting antiviral treatment for Hepatitis C during the measurement period PNM Patient did not start or is not receiving antiviral treatment for hepatitis C during the measurement period - PE

4 Page 4 of 9 Physician Quality Reporting Measure # 85 : Hepatitis C: Hepatitis C Virus (HCV) Genotype Testing Prior to Treatment Percentage of patients aged 18 years and older with a diagnosis of chronic Hepatitis C who started antiviral treatment within the 12-month reporting period for whom Hepatitis C virus (HCV) genotype testing was performed within 12 months prior to initiation of antiviral treatment Patients for whom HCV genotype testing was performed within 12 months prior to initiation of antiviral treatment Hepatitis C genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for Hepatitis C Patient starting antiviral treatment for Hepatitis C during the measurement period PM Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for Hepatitis C during the measurement period (e.g. Genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment) - PE Hepatitis C genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis C, reason not given Patient starting antiviral treatment for Hepatitis C during the measurement period - PNM Patient started antiviral treatment prior to the measurement period, patient not eligible

5 Page 5 of 9 Physician Quality Reporting Measure # 87 : Hepatitis C: Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Testing Between 4 12 Weeks After Initiation of Treatment Percentage of patients aged 18 years and older with a diagnosis of chronic Hepatitis C who are receiving antiviral treatment for whom quantitative Hepatitis C virus (HCV) ribonucleic acid (RNA) testing was performed between 4-12 weeks after the initiation of antiviral treatment Patients for whom quantitative HCV RNA testing was performed at no greater than 12 weeks from the initiation of antiviral treatment 4-12 Weeks after Initiation Patients for whom testing was performed between 4-12 weeks from the initiation of antiviral treatment will meet the numerator for this measure, acknowledging that there may be different recommended follow-up testing based on the specific antiviral therapy used to treat a particular patient. Measure #87 (patient not eligible) if initiation of antiviral treatment took place before October of the measurement year (12 weeks before the end of the measurement period) Performance Exclusion: (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons) Hepatitis C quantitative RNA testing documented as performed between 4-12 weeks after the initiation of antiviral treatment Patient receiving antiviral treatment for hepatitis C during the measurement period - PM Hepatitis C quantitative RNA testing not performed between 4-12 weeks after the initiation of antiviral treatment for Patient receiving antiviral treatment for Hepatitis C during the measurement period- PE documented in medical chart Clinician documented that patient is not an eligible candidate for quantitative RNA testing; patient not receiving antiviral treatment for Hepatitis C or antiviral treatment started on or after October 1 of the measurement year - PE Hepatitis C quantitative RNA testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given Patient receiving antiviral treatment for Hepatitis C documented - PNM Medical Patient

6 Page 6 of 9 Physician Quality Reporting Measure # 130 : Documentation of Current Medications in the Medical Record Percentage of visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. Eligible professional attests to documenting, updating or reviewing a patient s current medications using all immediate resources available on the date of encounter. This list must include ALL known prescriptions, over-the counters, herbals, and vitamin/mineral/dietary (nutritional) supplements must contain the medications name, dosages, frequency and route of administration Not Eligible - A patient is not eligible if the following reason is documented: Patient is in an urgent or emergent medical situation where time is of the essence and to delay treatment would jeopardize the patient s health status. Eligible professional attests to documenting in the medical record they obtained, updated, or reviewed the patient s current medications - PM Eligible professional attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible professional - PE Current list of medications not documented as obtained, updated, or reviewed by the eligible professional, reason not given - PNM For definitions and further information refer to the measures groups specifications manual

7 Page 7 of 9 Physician Quality Reporting Measure # 183 : Hepatitis C: Hepatitis A Vaccination Percentage of patients aged 18 years and older with a diagnosis of Hepatitis C who received at least one injection of Hepatitis A vaccine, or who have documented immunity to Hepatitis A Received Includes at least one injection of Hepatitis A vaccine during a current or prior visit, or previous receipt from another provider. Performance exclusion: Medical reason(s) for not administering at least one injection of hepatitis A vaccine (eg, allergy or intolerance to a known component of the vaccine, other medical reasons); Patient reason(s) for not administering at least one injection of hepatitis A vaccine (eg, patient declined, insurance coverage, other patient reasons) Hepatitis A vaccine injection administered or previously received - PM Patient has documented immunity to Hepatitis A - PM Hepatitis A vaccine injection not administered or previously received for documented in medical chart -PE Hepatitis A vaccine injection not received, reason not otherwise specified - PNM Medical Patient Physician Quality Reporting Measure # 226 : Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months who received cessation counseling intervention if identified as a tobacco user Note: In the event that a patient is screened for tobacco use and identified as a user but did not receive tobacco cessation counseling, choose answer option tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified. Tobacco Use includes any type of tobacco. Cessation Counseling Intervention includes brief counseling (3 minutes or less) and/or pharmacotherapy. Patient screened for tobacco use received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user - PM Current tobacco non-user - PM Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reasons) - PE Tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified - PNM

8 Page 8 of 9 Physician Quality Reporting Measure # 390 : Discussion and Shared Decision Making Surrounding Treatment Options Percentage of patients aged 18 years and older with a diagnosis of hepatitis C with whom a physician or other qualified healthcare professional reviewed the range of treatment options appropriate to their genotype and demonstrated a shared decision making approach with the patient. To meet the measure, there must be documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment - PM Treatment options not discussed for documented reasons: (Medical s: Patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons. Patient s: Patient unable or unwilling to participate in the discussion or other patient reasons - PE Medical Patient No documentation of a discussion in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment - PNM

9 Page 9 of 9 Physician Quality Reporting Measure # 401 : Screening for Hepatocellular Carcinoma (HCC) in Patient with Hepatitis C Cirrhosis Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12 month reporting period. Measure #401 only needs to be reported when the patient also has the following diagnosis code indicating cirrhosis: ICD-10-CM: K70.30, K70.31, K74.60, K74.69 Patient underwent abdominal imaging with ultrasound, contrast enhanced CT or contrast MRI for HCC - PM Screening for HCC not performed for documented reasons (Medical reason: Comorbid medical conditions with expected survival <5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons. Patient reason: Patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment) - PE Medical Patient Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period - PNM Patient does not have diagnosis indicating cirrhosis not eligible

2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) 2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory

More information

2016 Physician Quality Reporting System Data Collection Form: General Surgery (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: General Surgery (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: General Surgery (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

Physician Quality Reporting System (PQRS)

Physician Quality Reporting System (PQRS) Physician Quality Reporting System (PQRS) and the Value-Based Payment Modifier Implementation guide for registry-based reporting for the Hepatitis C (HCV) Measures Group 2015 1 Overview of PQRS 1,2 What

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

PQRS Claims Measures Details- Quick Reference 2014

PQRS Claims Measures Details- Quick Reference 2014 Measure Preventive Care and Screening: Body Mass Index (BMI) Screening and #128 Follow-up Medicare patients 18+ years of age, screened for BMI Normal: Age 65 years and older BMI > 23 and < 30 Age 18 to

More information

Management of Hepatitis C: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Management of Hepatitis C: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Performance ment Management of Hepatitis C: Review of the Performance s by the Performance ment Committee of the American College of Physicians Writing Committee Amir Qaseem, MD, Andrew Dunn, MD, Stephen

More information

An Overview of NYS Hepatitis C Testing Law. Statewide Stakeholder Meetings

An Overview of NYS Hepatitis C Testing Law. Statewide Stakeholder Meetings An Overview of NYS Hepatitis C Testing Law Statewide Stakeholder Meetings Agenda Overview of Hepatitis C virus (HCV) CDC HCV screening recommendations Review of HCV screening and diagnostic tests CDC HCV

More information

Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety

Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

INFLAMMATORY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW

INFLAMMATORY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW SPECIFICATION F MEASURES GROUP REPTING ONLY INFLAMMATY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW 2012 PHYSICIAN QUALITY REPTING OPTIONS F MEASURES GROUPS: REGISTRY ONLY 2012 PHYSICIAN QUALITY REPTING

More information

Reporting Audiology Quality Measures: A Step-by-Step Guide

Reporting Audiology Quality Measures: A Step-by-Step Guide What is PQRS? The Physician Quality Reporting System (PQRS) is a program through the Centers for Medicare and Medicaid Services (CMS) designed to improve the quality of care to Medicare beneficiaries by

More information

Hepatitis C Virus Direct-Acting Antivirals Prior Authorization Request Form

Hepatitis C Virus Direct-Acting Antivirals Prior Authorization Request Form Hepatitis C Virus Direct-Acting Antivirals Prior Authorization Request Form For assistance, please call 1-855-552-6028 or fax completed form to 570-271-5610. Medical documentation may be requested. This

More information

Prior Authorization Conditions for Approval of Hepatitis C Agents

Prior Authorization Conditions for Approval of Hepatitis C Agents Prior Authorization Conditions for Approval of Hepatitis C Agents All requests for Hepatitis C Agents require a prior authorization and will be screened for medical necessity and appropriateness using

More information

There have been significant

There have been significant Managing Clinical Quality Measures for Meaningful Use and PQRS Using the EHR Method These tips will make it easier to qualify. By Seth Flam, DO Charlieaja Dreamstime.com There have been significant changes

More information

Measure Title Measure Description Numerator Statement

Measure Title Measure Description Numerator Statement (NQF) Title Description Numerator 122v2 1 0059 Diabetes: Hemoglobin A1c Poor Control N/A 21 0268 Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalosporin Percentage

More information

A pharmacist s guide to Pharmacy Services compensation

A pharmacist s guide to Pharmacy Services compensation Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription

More information

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 MMWR August 17, 2012 Prepared by : The National Viral Hepatitis Technical Assistance Center

More information

PQRS Cheat Sheet. Occupational Therapy Reporting- Individual Measures

PQRS Cheat Sheet. Occupational Therapy Reporting- Individual Measures PQRS Cheat Sheet Occupational Therapy Reporting- Individual Measures Medicare requires that practitioners meet certain quality reporting thresholds and collect enough data to assess trends and performance.

More information

2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) 2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm

More information

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi

More information

HEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information. Diagnosis Acute Hep C Chronic Hep C Hepatocellular Carcinoma

HEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information. Diagnosis Acute Hep C Chronic Hep C Hepatocellular Carcinoma HEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information Recipient: MA#: Date of Birth: Phone #: Body Weight: Treatment Plan Sovaldi (sofosbuvir) 400mg: Take once daily for weeks Olysio

More information

MEDICAL POLICY STATEMENT

MEDICAL POLICY STATEMENT MEDICAL POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 5/21/2014 3/24/2016 3/24/2015 Policy Name Policy Number Hepatitis C Oral SRx-0003 Medical Policy Statements

More information

Physician Quality Reporting System (PQRS)

Physician Quality Reporting System (PQRS) Physician Quality Reporting System (PQRS) and the Value-Based Payment Modifier 2015 1 Implementation guide for registry-based reporting for the Inflammatory Bowel Disease (IBD) Measures Group Overview

More information

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300. April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the

More information

Occupational Therapy Reporting Individual Measures

Occupational Therapy Reporting Individual Measures Cheat Sheet Occupational Therapy Reporting Individual Measures This cheat sheet is designed to help you report the most possible G-code and CPT code by the PQRS measure. Measure #126 - Diabetes - Neurological

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Hepatitis C Infections in Oregon September 2014

Hepatitis C Infections in Oregon September 2014 Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with

More information

Numerator Details. - An acute or nonacute inpatient admission with a diagnosis of AOD (AOD Dependence

Numerator Details. - An acute or nonacute inpatient admission with a diagnosis of AOD (AOD Dependence Description Measure 0004: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) (National Committee for Quality Assurance) The percentage of adolescent and adult patients with

More information

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636) Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft

More information

ACO QUICK-REFERENCE SETUP GUIDE

ACO QUICK-REFERENCE SETUP GUIDE ACO QUICK-REFERENCE SETUP GUIDE FOR NON-eCW USERS V 9.0 eclinicalworks, 2013. All rights reserved Contents CONTENTS ACO SETUP 3 Demographics 3 ACO 12 4 ACO 13 5 ACO 14 5 ACO 15 7 ACO 16 8 ACO 17 15 ACO

More information

Physician Quality Reporting System What Neurosurgeons Need to Know for 2015

Physician Quality Reporting System What Neurosurgeons Need to Know for 2015 Physician Quality System What Neurosurgeons Need to Know for 2015 Prepared by the: American Association of Neurological Surgeons Congress of Neurological Surgeons For More Information Contact: Rachel Groman,

More information

Meaningful Use Qualification Plan

Meaningful Use Qualification Plan Meaningful Use Qualification Plan Overview Certified EHR technology used in a meaningful way is one piece of a broader Health Information Technology infrastructure intended to reform the health care system

More information

Summary of the risk management plan (RMP) for Harvoni (ledipasvir/sofosbuvir)

Summary of the risk management plan (RMP) for Harvoni (ledipasvir/sofosbuvir) EMA/702765/2014 Summary of the risk management plan (RMP) for Harvoni (ledipasvir/sofosbuvir) This is a summary of the risk management plan (RMP) for Harvoni, which details the measures to be taken in

More information

WHEREAS updates are required to the Compensation Plan for Pharmacy Services;

WHEREAS updates are required to the Compensation Plan for Pharmacy Services; M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta

More information

Coding and Billing. Commonly Asked Questions. Physician Office Reimbursement Guideline Q1. A1. Q2. A2.

Coding and Billing. Commonly Asked Questions. Physician Office Reimbursement Guideline Q1. A1. Q2. A2. Coding and Billing oorasure Technologies is pleased to provide you information on billing and reimbursement for HCV testing with the OraQuick HCV Rapid Antibody Test. Correctly identifying services delivered

More information

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011 Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment

More information

Hawaii Benchmarks Benefits under the Affordable Care Act (ACA)

Hawaii Benchmarks Benefits under the Affordable Care Act (ACA) Hawaii Benchmarks Benefits under the Affordable Care Act (ACA) 10/2012 Coverage for Newborn and Foster Children Coverage Outside the Provider Network Adult Routine Physical Exams Well-Baby and Well-Child

More information

PRIOR AUTHORIZATION POLICY

PRIOR AUTHORIZATION POLICY PRIOR AUTHORIZATION POLICY Harvoni (sofosbuvir/ledipasvir tablets Gilead) To initiate a Coverage Review, Call 1-800-417-1764 OVERVIEW Harvoni is a fixed-dose combination of ledipasvir, a hepatitis C virus

More information

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition

Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmologists can register for the Medicare electronic health record (EHR) incentive program on the CMS website: https://ehrincentives.cms.gov

More information

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf

More information

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences HBV & HCV induced Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences Definition of Cirrhosis Final pathway for a wide variety of chronic liver diseases

More information

January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose Important Changes for 2014 PQRS PQRS Incentive Individual EPs

January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose Important Changes for 2014 PQRS PQRS Incentive Individual EPs January 2014 Physician Quality Reporting System (PQRS): What s New for 2014 Purpose This fact sheet includes important information about changes to the Physician Quality Reporting System (PQRS) for 2014.

More information

Initial Preventive Physical Examination

Initial Preventive Physical Examination Initial Preventive Physical Examination Overview The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expanded Medicare's coverage of preventive services. Central to the Centers

More information

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco

More information

Iowa Wellness Plan Benefits Coverage List

Iowa Wellness Plan Benefits Coverage List Iowa Wellness Plan Benefits Coverage List Service Category Covered Duration, Scope, exclusions, and Limitations Excluded Coding 1. Ambulatory Services Primary Care Illness/injury Physician Services Should

More information

The following should be current within the past 6 months:

The following should be current within the past 6 months: EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,

More information

PREVENTIVE MEDICINE AND SCREENING POLICY

PREVENTIVE MEDICINE AND SCREENING POLICY REIMBURSEMENT POLICY PREVENTIVE MEDICINE AND SCREENING POLICY Policy Number: ADMINISTRATIVE 238.13 T0 Effective Date: January 1, 2016 Table of Contents APPLICABLE LINES OF BUSINESS/PRODUCTS... APPLICATION...

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #218 (NQF 0423): Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS

More information

Clinical Criteria for Hepatitis C (HCV) Therapy

Clinical Criteria for Hepatitis C (HCV) Therapy Diagnosis Clinical Criteria for Hepatitis C (HCV) Therapy Must have chronic hepatitis C, genotype and sub-genotype specified to determine the length of therapy; Liver biopsy or other accepted test demonstrating

More information

2013 ACO Quality Measures

2013 ACO Quality Measures ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating

More information

Innerview Reimbursement in the Physician Office Setting * 2014

Innerview Reimbursement in the Physician Office Setting * 2014 OVERVIEW This Guide is intended to assist with the process of billing and coding for Innerview, a Mental Health Clinical Decision Support System used in the primary care setting. Billing, coding and payment

More information

VIII. Dentist Crosswalk

VIII. Dentist Crosswalk Page 27 VIII. Dentist Crosswalk Overview The final rule on meaningful use requires that an Eligible Professional (EP) report on both clinical quality measures and functional objectives and measures. While

More information

Corporate Reimbursement Policy

Corporate Reimbursement Policy Corporate Reimbursement Policy Code Bundling Rules Not Addressed in ClaimCheck or Correct Coding Initiative File Name: code_bundling_rules_not_addressed_in_claim_check Origination: 6/2004 Last Review:

More information

Audit Proof Questioning the Answers. Massachusetts ehealth Collaborative (MAeHC)

Audit Proof Questioning the Answers. Massachusetts ehealth Collaborative (MAeHC) Audit Proof Questioning the Answers September 9 th, 2014 (MAeHC) The was created in 2004 under the leadership of the American College of Physicians and the Massachusetts Medical Society, and remains a

More information

Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016

Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016 Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016 Prior Authorization Requirement Yes No Not Applicable * Not covered by Medicare but is covered by HealthPartners Freedom

More information

Measure #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Measure #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care Measure #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

More information

NCQA PCMH 2011 Standards, Elements and Factors Documentation Guideline/Data Sources

NCQA PCMH 2011 Standards, Elements and Factors Documentation Guideline/Data Sources NCQA PCMH 2011 Standards, Elements and Factors Documentation Guideline/Data Sources Key: DP = Documented Process N/D = Report numerator and denominator creating percent of use RPT = Report of data or information

More information

Evaluation & Management Provider Compliance Summary Documentation Compliance Criteria for Evaluation & Management (E&M) Services

Evaluation & Management Provider Compliance Summary Documentation Compliance Criteria for Evaluation & Management (E&M) Services Evaluation & Management Provider Compliance Summary Documentation Compliance Criteria for Evaluation & Management (E&M) Services Date: April 23, 2012 Source Information: Medicare Policy Purpose The United

More information

:: Member Services Agreement ::

:: Member Services Agreement :: :: Member Services Agreement :: Member Services Agreement Welcome to Nextera Healthcare s direct primary care program for individuals, families and businesses. A monthly membership program centered on

More information

Understanding Coding & Reimbursement for SBI. Presented By: Jen Cohrs CPC, CPMA, CGIC Director of Educational Strategies Wisconsin Medical Society

Understanding Coding & Reimbursement for SBI. Presented By: Jen Cohrs CPC, CPMA, CGIC Director of Educational Strategies Wisconsin Medical Society Understanding Coding & Reimbursement for SBI Presented By: Jen Cohrs CPC, CPMA, CGIC Director of Educational Strategies Wisconsin Medical Society CPT codes, descriptions and material only are Copyright

More information

CHRONIC CARE MANAGEMENT TOOL KIT What Practices Need to Do to Implement and Bill CCM Codes

CHRONIC CARE MANAGEMENT TOOL KIT What Practices Need to Do to Implement and Bill CCM Codes CHRONIC CARE MANAGEMENT TOOL KIT What Practices Need to Do to Implement and Bill CCM Codes Understanding CCM Chronic Care Management (CCM) is defined as the non-face-to-face services provided to Medicare

More information

BEACON HEALTH STRATEGIES, LLC TELEHEALTH PROGRAM SPECIFICATION

BEACON HEALTH STRATEGIES, LLC TELEHEALTH PROGRAM SPECIFICATION BEACON HEALTH STRATEGIES, LLC TELEHEALTH PROGRAM SPECIFICATION Providers contracted for the telehealth service will be expected to comply with all requirements of the performance specifications. Additionally,

More information

Summary of Services and Cost Shares

Summary of Services and Cost Shares Summary of Services and Cost Shares This summary does not describe benefits. For the description of a benefit, including any limitations or exclusions, please refer to the identical heading in the Benefits

More information

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.

More information

Liver Cancer And Tumours

Liver Cancer And Tumours Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can

More information

Meaningful Use. Stage 1

Meaningful Use. Stage 1 Meaningful Use Stage 1 Core Objectives Must Meet all 13 Objectives 1. CPOE for Medication Orders 2. Drug Interaction Checks 3. Up-To-Date Problem List 4. E-Prescribing (erx) 5. Active Medication List 6.

More information

GUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION POLICY BRIEF

GUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION POLICY BRIEF NEW RECOMMENDATIONS IN THE UPDATED WHO GUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION POLICY BRIEF NEW RECOMMENDATIONS IN THE UPDATED WHO GUIDELINES FOR

More information

Frequently Asked Questions for the Pediatric Immunization Administration Codes

Frequently Asked Questions for the Pediatric Immunization Administration Codes 2015 Frequently Asked Questions for the Pediatric Immunization Administration Codes Component Definition Old versus New IA Codes Counseling and OQHCP Documentation Requirements When to still report 90471-90474

More information

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet s Preventive Care Services Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet What do the kidneys do? Your kidneys have important jobs to do in your body. Two of the kidneys most important jobs

More information

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed

More information

Meaningful Use: Stage 3 Proposed Rule Chart

Meaningful Use: Stage 3 Proposed Rule Chart Meaningful Use: Stage 3 Rule Chart Objectives: Objective 1-Protect Patient Health Information: Protect electronic protected health information (ephi) created or maintained by the CEHRT through the implementation

More information

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

IRG/APS Healthcare Utilization Management Guidelines for West Virginia Health Homes - Bipolar and Hepatitis

IRG/APS Healthcare Utilization Management Guidelines for West Virginia Health Homes - Bipolar and Hepatitis IRG/APS Healthcare Utilization Management Guidelines for West Virginia Health Homes - Bipolar and Hepatitis CHANGE LOG Medicaid Chapter Policy # Effective Date Chapter 535 Health Homes 535.1 Bipolar and

More information

Meaningful Use - The Basics

Meaningful Use - The Basics Meaningful Use - The Basics Presented by PaperFree Florida 1 Topics Meaningful Use Stage 1 Meaningful Use Barriers: Observations from the field Help and Questions 2 What is Meaningful Use Meaningful Use

More information

Cigna Open Access Plans for Tennessee

Cigna Open Access Plans for Tennessee Individual & Family Plans Insured by Connecticut General Life Insurance Company Cigna Open Access Plans for Tennessee medical & PHARMACY INSURANCE with the ONE-AND-ONLY YOU IN MIND. 858436 a 12/12 Services

More information

2013 Meaningful Use Dashboard Calculation Guide

2013 Meaningful Use Dashboard Calculation Guide 2013 Meaningful Use Dashboard Calculation Guide Learn how to use Practice Fusion s Meaningful Use Dashboard to help you achieve Meaningful Use. For more information, visit the Meaningful Use Center. General

More information

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs) Meaningful Use Criteria for Eligible and Eligible Professionals (EPs) Under the Electronic Health Record (EHR) meaningful use final rules established by the Centers for Medicare and Medicaid Services (CMS),

More information

Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over

Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over 1. BMI - Documented in patients medical record on an annual basis up to age 74. Screen for obesity and offer counseling to encourage

More information

Executive summary of recommendations

Executive summary of recommendations MOH CLINICAL PRACTICE GUIDELINES 2/2011 Chronic Hepatitis B Infection College of Family Physicians, Singapore Academy of Medicine, Singapore Singapore Medical Association Executive summary of recommendations

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL HEPATOCELLULAR CARCINOMA GI Site Group Hepatocellular Carcinoma Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION

More information

Klamath Tribal Health & Family Services 3949 South 6 th Street Klamath Falls, OR 97603

Klamath Tribal Health & Family Services 3949 South 6 th Street Klamath Falls, OR 97603 Klamath Tribal Health & Family Services 3949 South 6 th Street Klamath Falls, OR 97603 Phone: (541) 882-1487 or 1-800-552-6290 HR Fax: (541) 273-4564 OPEN: 10/02/12 CLOSE: WHEN FILLED POSITION: RESPONSIBLE

More information

HEART FAILURE NATIONAL HOSPITAL INPATIENT QUALITY MEASURES. Measure Short Name. Adult Smoking Cessation Advice/Counseling

HEART FAILURE NATIONAL HOSPITAL INPATIENT QUALITY MEASURES. Measure Short Name. Adult Smoking Cessation Advice/Counseling Release Notes: Measure Information Form Version 2.6 HEART FAILURE NATIONAL HOSPITAL INPATIENT QUALITY MEASURES Set Measure ID # HF-2 Discharge Instructions Evaluation of LVS Function ACEI or ARB for LVSD

More information

How to Bill for a School-Based Clinic

How to Bill for a School-Based Clinic How to Bill for a School-Based Clinic MDwise.org MDwise is a Hoosier Healthwise/HIP Plan A Hoosier Healthwise/HIP Plan Table of Contents Introduction... 3 The Importance of School-Based Clinics... 3 Covered

More information

Compensation Plan for Pharmacy Services

Compensation Plan for Pharmacy Services Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue

More information

Cirrhosis and HCV. Jonathan Israel M.D.

Cirrhosis and HCV. Jonathan Israel M.D. Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment

More information

Meaningful Use Stage 2 Implementation Guide

Meaningful Use Stage 2 Implementation Guide Meaningful Use Stage 2 Implementation Guide Copyright 2014 Kareo, Inc. All rights reserved. Updated October 2014 Table of Contents Get Ready... 1 Task List: Meaningful Use Stage 2... 2 Basic Training...

More information

Purdue Research Foundation

Purdue Research Foundation PQRS: Leveraging Technology to Improve Quality and Ease Reporting Burdens Tara Hatfield RN, BSN, CHTS-CP Managing Advisor MU/PQRS Purdue Healthcare Advisors Objectives Understand the impact of the PQRS

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON

More information

The CMS EHR Incentive Programs: Small-Practice Providers and Clinical Quality Measures

The CMS EHR Incentive Programs: Small-Practice Providers and Clinical Quality Measures The CMS EHR Incentive Programs: Small-Practice Providers and Clinical Quality Measures October 25, 2011 1:00 p.m. ET Schedule Agenda Time Introduction and Welcome 1:00 to 1:10 Presentation by CMS Experts

More information

Professional Practice Medical Record Documentation Guidelines

Professional Practice Medical Record Documentation Guidelines Professional Practice Medical Record Documentation Guidelines INTRODUCTION Consistent and complete documentation in the medical record is an essential component of quality patient care. All Participating

More information

Stage 3 Meaningful Use

Stage 3 Meaningful Use Stage 3 Meaningful Use In October 2015, CMS released the Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3 and Modifications to Meaningful Use in 2015 through 2017 final

More information

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age 18 64 years BMI 18.5 and < 25 kg/m 2

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age 18 64 years BMI 18.5 and < 25 kg/m 2 Measure #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2015 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

EHR Incentive Program Focus on Stage One Meaningful Use. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014

EHR Incentive Program Focus on Stage One Meaningful Use. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014 EHR Incentive Program Focus on Stage One Meaningful Use Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com October 16, 2014 Checklist Participation Explanation Program Updates Stage One

More information

New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid

New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid Update December 2009 No. 2009-96 Affected Programs: BadgerCare Plus, Medicaid To: All Providers, HMOs and Other Managed Care Programs New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare

More information

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.

More information

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Presented by Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Meaningful Use is using certified EHR technology to: Improve quality, safety, efficiency, and reduce errors Engage

More information

Guide To Meaningful Use

Guide To Meaningful Use Guide To Meaningful Use Volume 1 Collecting the Data Contents INTRODUCTION... 3 CORE SET... 4 1. DEMOGRAPHICS... 5 2. VITAL SIGNS... 6 3. PROBLEM LIST... 8 4. MAINTAIN ACTIVE MEDICATIONS LIST... 9 5. MEDICATION

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Hepatitis C Agents A. Prescriptions That Require Prior Authorization Prescriptions for Pegasys and non-preferred Hepatitis C Agents must

More information

A Guide to Patient Services. Cedars-Sinai Health Associates

A Guide to Patient Services. Cedars-Sinai Health Associates A Guide to Patient Services Cedars-Sinai Health Associates Welcome Welcome to Cedars-Sinai Health Associates. We appreciate the trust you have placed in us by joining our dedicated network of independent-practice

More information